TY - JOUR
T1 - Mood disorders affect drug treatment success of drug-dependent pregnant women
AU - Fitzsimons, Heather E.
AU - Tuten, Michelle
AU - Vaidya, Varsha
AU - Jones, Hendrée E.
N1 - Funding Information:
The authors wish to thank Renee Cieslak and Candice Evans for assistance with data collection, as well as all staff members and patients at the CAP. Portions of these data were presented at the 2003 College on Problems of Drug Dependence scientific meeting. This research was supported by NIDA grant 12403.
Funding Information:
This research was supported by the National Institute on Drug Abuse Grant R01 DA12403.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/1
Y1 - 2007/1
N2 - This study examined the impact of co-occurring Axis I disorders on drug treatment outcomes of drug-dependent pregnant women. Participants (N = 106) were women who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for opioid dependence and were receiving methadone. Based on DSM-IV Axis I criteria, participants were categorized into three groups: (1) absence of mood/anxiety disorder (ND, n = 29), (2) primary mood disorder (MD, n = 39), or (3) primary anxiety disorder (AD, n = 38). Demographically, the groups were similar. The MD group was significantly more likely to be positive for drugs while in treatment compared with both the ND and AD groups. The MD and AD groups had more psychosocial impairment and higher incidence of suicidal ideation compared with the ND group. Interestingly, the AD group spent more days in treatment compared with the ND or MD group. These findings highlight the need to treat co-occurring Axis I disorders, particularly given the higher relapse risk for those with mood disorders.
AB - This study examined the impact of co-occurring Axis I disorders on drug treatment outcomes of drug-dependent pregnant women. Participants (N = 106) were women who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for opioid dependence and were receiving methadone. Based on DSM-IV Axis I criteria, participants were categorized into three groups: (1) absence of mood/anxiety disorder (ND, n = 29), (2) primary mood disorder (MD, n = 39), or (3) primary anxiety disorder (AD, n = 38). Demographically, the groups were similar. The MD group was significantly more likely to be positive for drugs while in treatment compared with both the ND and AD groups. The MD and AD groups had more psychosocial impairment and higher incidence of suicidal ideation compared with the ND group. Interestingly, the AD group spent more days in treatment compared with the ND or MD group. These findings highlight the need to treat co-occurring Axis I disorders, particularly given the higher relapse risk for those with mood disorders.
KW - Addiction
KW - Dual diagnosis
KW - Pregnancy
KW - Treatment outcomes
UR - http://www.scopus.com/inward/record.url?scp=33845414045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845414045&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2006.06.015
DO - 10.1016/j.jsat.2006.06.015
M3 - Article
C2 - 17175395
AN - SCOPUS:33845414045
SN - 0740-5472
VL - 32
SP - 19
EP - 25
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 1
ER -